Anastassov George
Transaction: 11/14/2025
BUY
Change
+1,686,956
Price
Not reported
Filing
11/14/2025
Type
BUY
Incannex Healthcare Limited
IXHL • Biotechnology
$2.75
▼ -0.01 (-0.53%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$33.90M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 48.81Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Sep 27, 2026, 12:05 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.75
Change-0.53%
Shares Out12.35M
Market Cap$33.90M
Enterprise Value$-33.71M
52W Range2.49 - 19.71
Beta2.83
P/E-0.68
P/S508.91
P/B0.50
P/FCF-1.64
EV/Sales-506.09
Price$2.75
Change-0.53%
Shares Out12.35M
Market Cap$33.90M
Enterprise Value$-33.71M
52W Range2.49 - 19.71
Beta2.83
P/E-0.68
P/S508.91
P/B0.50
P/FCF-1.64
EV/Sales-506.09
EV/EBITDA0.63
EV/FCF1.64
Earnings Yield-147.32%
FCF Yield-60.81%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio48.81
Quick Ratio48.81
Volume144.74K
Avg Volume194.89K
EPS Surprise0.25
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 48.81Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Latham Joel
Transaction: 11/14/2025
BUY
Change
+22,608,692
Price
Not reported
Filing
11/14/2025
Type
BUY
Swan Joseph
Transaction: 11/14/2025
BUY
Change
+869,565
Price
Not reported
Filing
11/14/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Anastassov George | BUY | +1,686,956 | Not reported | 11/14/2025 | 11/14/2025 |
| Latham Joel | BUY | +22,608,692 | Not reported | 11/14/2025 | 11/14/2025 |
| Swan Joseph | BUY | +869,565 | Not reported | 11/14/2025 | 11/14/2025 |
| Widdows Peter | BUY | +1,686,956 | Not reported | 11/14/2025 | 11/14/2025 |
| Clark Robert | BUY | +1,686,956 | Not reported | 11/14/2025 | 11/14/2025 |
| Valentine Troy | BUY | +11,302,608 | Not reported | 11/14/2025 | 11/14/2025 |
| Barbato Luigi M. | BUY | +100,476 | Not reported | 10/23/2024 | 10/24/2024 |
| Barbato Luigi M. | OTHER | 0 | Not reported | 10/21/2024 | 10/24/2024 |
| Swan Joseph | OTHER | 0 | Not reported | 06/30/2024 | 08/02/2024 |
| Swan Joseph | BUY | +50,793 | Not reported | 05/06/2024 | 08/02/2024 |
| Clark Robert | BUY | +100,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Anastassov George | BUY | +100,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Latham Joel | BUY | +1,340,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Widdows Peter | BUY | +100,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Valentine Troy | BUY | +670,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Clark Robert | SELL | -25,000 | $65.75 | 11/28/2023 | 12/08/2023 |
| Latham Joel | SELL | -9,334 | $17.10 | 11/28/2023 | 12/06/2023 |
| Latham Joel | SELL | 0 | Not reported | 11/28/2023 | 12/06/2023 |
| Swan Joseph | SELL | -1,000 | $20.39 | 11/28/2023 | 12/06/2023 |
| Swan Joseph | SELL | 0 | Not reported | 11/28/2023 | 12/06/2023 |